ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
Titel:
ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
Auteur:
Maithel, Shishir K. Keilson, Jessica M. Cao, Hop S. Tran Rupji, Manali Mahipal, Amit Lin, Bruce S. Javle, Milind M. Cleary, Sean P. Akce, Mehmet Switchenko, Jeffrey M. Rocha, Flavio G.